Canada · Health Canada Drug Product Database

CEO-TWO BOWEL EVACUANT SUPPOSITORIES

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
28431
DIN
02090074
Form
Suppository
Company as listed by source
BEUTLICH L.P.
Source status
Cancelled Post Market (2003-07-30)
Source last updated
2025-03-22

Source-listed ingredients

  • SODIUM BICARBONATE — 627 MG
  • POTASSIUM BITARTRATE — 942 MG

These values do not establish equivalence or a dose recommendation.

Packages

  • 10

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →
CEO-TWO BOWEL EVACUANT SUPPOSITORIES — Canada | Molindra Medicines